top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Blood Group Typing Market - Competitive Landscape and Key Product Segments

0 votes
4 views

Transparency Market Research (TMR) has published a new report titled, “Blood Group Typing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 to 2026.” According to the report, the global blood group typing market was valued at US$ 1,500.0 Mn in 2017 and is projected to reach US$ 3,556.0 Mn by 2026, expanding at a high CAGR of 10.3% from 2018 to 2026. Increase in blood transfusion rate across the world is anticipated to fuel the global blood group typing market during the forecast period.

Planning To Lay Down Future Strategy? Request Brochure Of Blood Group Typing Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48627

North America and Europe are expected to dominate the global market during the forecast period. The market in these regions is primarily driven by the increase in government initiatives and a highly structured health care industry. The market in Europe is projected to expand at a high growth rate of 10.1% from 2018 to 2026. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. The market in Asia Pacific is anticipated to expand at a high CAGR of 10.7% from 2018 to 2026. The blood group typing market in Latin America is likely to expand at a moderate growth rate during the forecast period.

Increase in preference for PCR-based technique to boost market

In terms of technique, the PCR-based segment is projected to account for a dominant share of the global blood group typing market during the forecast period. The segment is anticipated to expand at a CAGR of 10.6% from 2018 to 2026. Dominance of the segment is attributed to the increasing preference for PCR-based technique because of rising incidence of major chronic diseases such as aplastic anemia, sickle cell anemia, leukemia, and traumatic injuries, resulting increase in blood transfusion rate in countries across the globe.

Additionally, increasing the usage of PCR-based technique in the detection of rare type of blood group is a key factor that is expected to fuel the segment. The microarray-based segment held a major share of the market, following the PCR-based segment, due to increasing awareness about this technique. Assay-based technique and massively parallel technique segments accounted for around 30.0% share of the global blood group typing market, in terms of revenue, in 2017.

Consumables segment dominates the market

The report offers detailed segmentation of the global blood group typing market based on product, technique, test, and end-user. In terms of product, the market has been classified into instrument (automated, semi-automated, and manual), consumables (reagent, test kits, antisera, others), and services. The consumables segment is estimated to hold a leading share of the global market during the forecast period. Higher share held by the segment is attributed to the constant development of new molecular diagnostic test kits and reagents, which reduces the turnaround time required for results, and increase in number of blood transfusions, globally, every year are key factors fueling the consumables segment.

Antibody screening test & ABO blood test: Top two test employed for blood group typing

In terms of test, the antibody screening test segment is projected to hold a dominant share of global blood group typing market by the end of the forecast period. The segment is likely to expand at a CAGR more than 10.0% between 2018 and 2026. Major factor responsible for the dominance of this segment is the rise in incidence of transfusion transmitted infections (TTIs), especially in lower-middle income and low-income countries. The ABO blood test segment held a major share, following the antibody screening test, due to increasing utilization of this test for blood grouping. HLA typing and antigen segments accounted for around 30.0% share of the global blood group typing market, in terms of revenue, in 2017.

To Obtain All-Inclusive Information On Forecast Analysis Of Blood Group Typing Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=48627

Hospital segment to expand at significant CAGR

Based on end-user, the hospital segment accounted for a leading share of the global blood group typing market in 2017. It is projected to gain market share by the end of 2026. The segment is anticipated to expand at a CAGR of 10% during the forecast period due to the large patient population undergoing surgical procedures in hospitals requiring blood transfusion, and increasing emphasis on blood grouping and patient testing. Clinical laboratories was a prominent segment, following the hospital segment, of the market in 2017. This is due to the rise in number of clinical laboratories for blood grouping and screening. This, in turn, is likely to drive the clinical laboratories segment during the forecast period.

North America to be highly lucrative market for blood group typing market

The blood group typing market in North America is driven by high percentage of active and voluntary blood donors in the U.S. and Canada, increasing number of blood transfusions per year in the region, and various blood transfusion policies being implemented regarding safety and testing of blood for infectious diseases. This, in turn, is further boosting the demand for blood grouping instruments and kits and reagents in North America. Moreover, a large number of players in the U.S. are focusing on R&D in order to introduce new products. The U.S. is an early adopter of innovative products, as most pharmaceutical products are first launched in the country. This is likely to boost the market in the country in the near future.

Trend of strategic alliance with local companies to strengthen distribution network and expand geographic presence

The global blood group typing market is fragmented, owing to the presence of several small- and large-scale companies. However, the market is dominated by a few major players with strong global presence. The report provides profiles of leading players operating in the global blood group typing market. Key players in the market include Grifols, S. A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, QUOTIENT LIMITED, BAG Health Care GmbH, Immucor, Inc., Beckman Coulter, Inc. (Danaher Corporation), Agena Bioscience, Inc., Rapid Labs Ltd, and Novacyt Group.

posted Feb 12 by Rohini Chaudhari

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Transparency Market Research (TMR) has published a new report titled, “Blood Group Typing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 to 2026.” According to the report, the global blood group typing market was valued at US$ 1,500.0 Mn in 2017 and is projected to reach US$ 3,556.0 Mn by 2026, expanding at a high CAGR of 10.3% from 2018 to 2026. Increase in blood transfusion rate across the world is anticipated to fuel the global blood group typing market during the forecast period.

Planning To Lay Down Future Strategy? Request Brochure Of Blood Group Typing Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48627

North America and Europe are expected to dominate the global market during the forecast period. The market in these regions is primarily driven by the increase in government initiatives and a highly structured health care industry. The market in Europe is projected to expand at a high growth rate of 10.1% from 2018 to 2026. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. The market in Asia Pacific is anticipated to expand at a high CAGR of 10.7% from 2018 to 2026. The blood group typing market in Latin America is likely to expand at a moderate growth rate during the forecast period.

Increase in preference for PCR-based technique to boost market

In terms of technique, the PCR-based segment is projected to account for a dominant share of the global blood group typing market during the forecast period. The segment is anticipated to expand at a CAGR of 10.6% from 2018 to 2026. Dominance of the segment is attributed to the increasing preference for PCR-based technique because of rising incidence of major chronic diseases such as aplastic anemia, sickle cell anemia, leukemia, and traumatic injuries, resulting increase in blood transfusion rate in countries across the globe.

Additionally, increasing the usage of PCR-based technique in the detection of rare type of blood group is a key factor that is expected to fuel the segment. The microarray-based segment held a major share of the market, following the PCR-based segment, due to increasing awareness about this technique. Assay-based technique and massively parallel technique segments accounted for around 30.0% share of the global blood group typing market, in terms of revenue, in 2017.

Consumables segment dominates the market

The report offers detailed segmentation of the global blood group typing market based on product, technique, test, and end-user. In terms of product, the market has been classified into instrument (automated, semi-automated, and manual), consumables (reagent, test kits, antisera, others), and services. The consumables segment is estimated to hold a leading share of the global market during the forecast period. Higher share held by the segment is attributed to the constant development of new molecular diagnostic test kits and reagents, which reduces the turnaround time required for results, and increase in number of blood transfusions, globally, every year are key factors fueling the consumables segment.

Antibody screening test & ABO blood test: Top two test employed for blood group typing

In terms of test, the antibody screening test segment is projected to hold a dominant share of global blood group typing market by the end of the forecast period. The segment is likely to expand at a CAGR more than 10.0% between 2018 and 2026. Major factor responsible for the dominance of this segment is the rise in incidence of transfusion transmitted infections (TTIs), especially in lower-middle income and low-income countries. The ABO blood test segment held a major share, following the antibody screening test, due to increasing utilization of this test for blood grouping. HLA typing and antigen segments accounted for around 30.0% share of the global blood group typing market, in terms of revenue, in 2017.

To Obtain All-Inclusive Information On Forecast Analysis Of Blood Group Typing Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=48627

Hospital segment to expand at significant CAGR

Based on end-user, the hospital segment accounted for a leading share of the global blood group typing market in 2017. It is projected to gain market share by the end of 2026. The segment is anticipated to expand at a CAGR of 10% during the forecast period due to the large patient population undergoing surgical procedures in hospitals requiring blood transfusion, and increasing emphasis on blood grouping and patient testing. Clinical laboratories was a prominent segment, following the hospital segment, of the market in 2017. This is due to the rise in number of clinical laboratories for blood grouping and screening. This, in turn, is likely to drive the clinical laboratories segment during the forecast period.

North America to be highly lucrative market for blood group typing market

The blood group typing market in North America is driven by high percentage of active and voluntary blood donors in the U.S. and Canada, increasing number of blood transfusions per year in the region, and various blood transfusion policies being implemented regarding safety and testing of blood for infectious diseases. This, in turn, is further boosting the demand for blood grouping instruments and kits and reagents in North America. Moreover, a large number of players in the U.S. are focusing on R&D in order to introduce new products. The U.S. is an early adopter of innovative products, as most pharmaceutical products are first launched in the country. This is likely to boost the market in the country in the near future.

Trend of strategic alliance with local companies to strengthen distribution network and expand geographic presence

The global blood group typing market is fragmented, owing to the presence of several small- and large-scale companies. However, the market is dominated by a few major players with strong global presence. The report provides profiles of leading players operating in the global blood group typing market. Key players in the market include Grifols, S. A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, QUOTIENT LIMITED, BAG Health Care GmbH, Immucor, Inc., Beckman Coulter, Inc. (Danaher Corporation), Agena Bioscience, Inc., Rapid Labs Ltd, and Novacyt Group.

0 votes

Elbow Lesion Treatment Market: Introduction

Elbow lesion are injuries that disrupt the cartilage and subjacent bone, and most commonly involve the capitellum. Factors that can result in elbow lesion include genetics, improper nutrition, and trauma. The staging, prognosis, and treatment of lesions in the elbow are based on a combination of radiographic, magnetic resonance imaging, and arthroscopic findings.

Report Overview @ https://www.transparencymarketresearch.com/elbow-lesion-treatment-market.html

Elbow lesion is most often seen in adolescents aged between 12 years and 16 years who are throwing athletes, overhead athletes, or upper extremity weight bearing athletes. Baseball and gymnastics are common sports of patients with capitellar osteochondritis lesions. It is perceived to be due to repetitive microtrauma to the capitellum with valgus elbow loading. 

Key Drivers and Restraints of Global Elbow Lesion Treatment Market

Health care awareness and rise in adventure sports have led to an increase in the incidence rate of sports injuries. The Centers for Disease Control and Prevention (CDC) 2015 report suggests that athletes in universities and high schools account for approximately 2 million injuries, 50,000 doctor visits, and 30,000 
hospitalizations every year in the U.S. Increase in the incidence rate of sports injuries among youth is due to much pressure on joints and repeated small trauma injuries. Therefore, increased participation in sports and exercise has led to a rise in sports-related injuries, and consequently higher demand for elbow lesions management products such as elbow splints.

Request PDF Sample of Elbow Lesion Treatment Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74063

Large number of global manufacturers who have technical expertise and core competencies are undertaking constant efforts to develop and manufacture novel elbow lesion treatment products. Improved biomaterial-based products with high strength and low wear are witnessing an exponential rise in demand in developed as well as developing countries. Moreover, there is a rise in the adoption of minimally invasive surgery (MIS), navigation technology, 3D-bioprinting, and tissue engineering. Affordability, ease of utility, and novelty are key factors for product developers to cater to the increasing demand of the rapidly growing population affected by orthopedic diseases.

Surgical Treatment Segment to Dominate Global Elbow Lesion Treatment Market

In terms of type, the surgical treatment segment is expected to dominate the global elbow lesion treatment market during the forecast period. Arthroscopic surgery and open surgery are types of surgical therapies performed for elbow lesion. Non-surgical therapies comprise drugs, such as NSAIDS, and physical therapy.

Incidence of accidental injuries during sports, driving, and adventure has increased drastically in the past decade. According to Centers for Disease Control and Prevention (CDC), every year, over 2 million patients visit the U.S. emergency departments for head trauma related injuries.

North America to Lead Global Elbow Lesion Treatment Market

Based on region, the global elbow lesions treatment market can be segmented into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa

North America is expected to lead the global elbow lesions treatment market. The North America elbow lesion treatment market is driven by a well-established health care infrastructure in the region. This has led to a rise in the number of surgeries, thereby boost the region’s market share.

Pre Book “Elbow Lesion Treatment Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=74063&ltype=S

This market in Europe is projected to expand due to the growing patient pool of geriatric population, high incidences of lifestyle disorders, and technological advancements

Asia Pacific elbow lesion treatment market is anticipated to witness rapid growth, owing to rise in medical tourism, increasing efforts by governments of the developing countries to better the health care infrastructure, and technological advancements

Key Manufacturers Operating in Global Elbow Lesion Treatment Market

The global market for elbow lesion treatment is moderately fragmented with market players focusing on strategically important partnerships, collaborations, mergers, acquisitions, and product launched. Key manufacturers operating in the global market are:

Arthrex, Inc.
Stryker
Zimmer Biomet
DePuy Synthes (Johnson & Johnson)
Exactech, Inc.
Cesca Therapeutics Inc,
Cesca Therapeutics
Hanger, Inc.
Fillauer LLC

More Trending Reports by Transparency Market Research –

Schizophrenia Drugs Market: https://www.prnewswire.com/news-releases/patent-expiry-of-notable-drugs-to-open-up-plethora-of-opportunities-for-key-players-in-global-schizophrenia-drugs-market-transparency-market-research-300998435.html

Haemostasis Valves Market: https://www.prnewswire.com/news-releases/haemostasis-valves-market-promises-a-buoyant-path-to-growth-with-4-5-cagr-during-2019-2027-amidst-rising-cases-of-cancer-transparency-market-research-300998401.html

0 votes

Transparency Market Research (TMR) has published a new report titled, “Surgical Drainage Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global surgical drainage devices market was valued at US$ 3 Bn in 2017 and is projected to expand at a CAGR of 4% from 2018 to 2026. The report suggests that increase in number of surgeries, surge in geriatric population, and rise in incidence of target diseases are likely to fuel the growth of the global surgical drainage devices market from 2018 to 2026.

North America and Europe are projected to dominate the global surgical drainage devices market in the next few years, owing to rise in number of orthopedic surgeries such as hip replacement and knee replacement, and high per capita health care expenditure. Several key industry events have been documented in the global surgical drainage devices market. Raising medical standards in China and other countries in Asia Pacific, and increase in usage of image guided drainage devices is expected to boost the growth of the global surgical drainage devices market during the forecast period.

Active Drainage Segment Held Largest Market Share

The report offers detailed segmentation of the global surgical drainage devices market based on product type. The active drainage segment is projected to account for the largest market share in 2026. The segment is anticipated to grow at a rapid pace, as active drainage provides higher efficiency in wound healing than passive drainage. Usage of closed suction surgical drains reduces the risk of hematoma formation and infections in the operation site. Surgical suction devices monitor the presence of excess fluid at the operation site and drain out the excess fluid from it at pre-programmed time. Premature removal of surgical drainage system may lead to infection.

Request PDF Sample of Surgical Drainage Devices Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21800

Orthopedics Segment to Capture Largest Market Share

The orthopedics segment held the largest market share in 2017. The segment is projected to expand at a significant growth rate during the forecast period. Rise in prevalence of musculoskeletal diseases such as rheumatoid arthritis, lupus erythematous, and osteoporosis, and surge in number of orthopedic procedures such as hip replacement and knee replacement are expected to drive the orthopedic segment during the forecast period.

Closed suction drains are predominantly used in orthopedic surgeries in large joint arthroplasties to reduce the risk of post-operative hematoma formation. In some cases, orthopedic physicians doubt that there may be a case of leakage from the wound, particularly in total knee replacement, if they do not use surgical drains. The neurosurgery segment is set to expand at the highest growth rate during the forecast period, owing to rise in complications in neurosurgery, increase in cases of surgical site infection during neurosurgery.

Hospitals Segment to Account for Largest Market Share and Expand at the Fastest CAGR

The hospitals segment held the largest market share in 2017. The segment is anticipated to expand at the fastest CAGR during the forecast period. Hospitals are the preferred choice among people and are highly favorable settings for surgical procedures due to safe health care treatment procedures, health care insurance coverage, availability of advanced health care technology, and beds for a large number of people.

Asia Pacific Market to be driven by Rise in Population in China and India

In terms of revenue, North America is likely to continue to dominate the global surgical drainage devices market in 2017, owing to significant number of surgeries, rise in adoption of surgical drainage devices to decrease the risk of post-surgical infections, presence of key market leaders, and technological advancements. The market in Asia Pacific is anticipated to expand at the highest CAGR during the forecast period. The market in the region is primarily driven by increase in population in India and China, rise in the number of trauma and burn cases, developing health care infrastructure, presence of key market leaders, and participation of domestic players. Increase in adoption of technologically advanced equipment and trend of cost-effective health care services are the major factors expected to fuel the growth of the independent clinics segment in Asia Pacific from 2018 to 2026.

Buy Now “Surgical Drainage Devices Market ” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=21800&ltype=S

Acelity, Smith & Nephew, ConvaTec, and Cardinal Health Dominate the Market

The report also provides profiles of leading players operating in the global surgical drainage devices market. Acelity, Smith & Nephew, ConvaTec, and Cardinal Health are the major players operating in the market, offering products with proprietary technologies. Other players include B. Braun Melsungen AG, BD, Cook Medical, Medtronic, Teleflex Incorporated, Stryker, Johnson and Johnson, REDAX, Integra LifeSciences, and Medela AG. Major industry events related to the market are acquisition of C. R. Bard by BD for US$ 24 Bn in November 2017, acquisition of OrthoD Group (a U.K.-based company on wound drainage and other fixation devices) by Apposite Capital in March 2018, acquisition of Argon Medical Devices (a U.S.-based company on drainage catheter) by Shandong Weigao Group Medical Polymer Co in September 2017.

More Trending Reports by Transparency Market Research –

Erectile Dysfunction Drugs Market: prnewswire.com/news-releases/erectile-dysfunction-drugs-market-is-expected-to-reach-usd-34-billion-globally-in-2019-transparency-market-research-228593931.html

Veterinary Drugs Market: prnewswire.com/news-releases/veterinary-drugs-market-to-reach-us267-bn-by-2024-rising-inclination-toward-ensuring-health-and-wellness-of-companion-animals-to-aid-growth-says-tmr-615866193.html

0 votes
  • According to Transparency Market Research’s latest report on the global mHealth monitoring diagnostic medical devices market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of chronic disorders, aging population, technological advancements, entry of new players, and increase in access to health care are projected to drive the global mHealth monitoring diagnostic medical devices market
  • According to the report, the global mHealth monitoring diagnostic medical devices market was valued at US$ 29.05 Bn in 2018 and is projected to expand at a CAGR of 20.5% from 2019 to 2027

Rise in Prevalence of Chronic Disorders and Increase in Government Initiatives: Key Drivers

  • Prevalence of disease indications such as diabetes, cardiovascular diseases, and other chronic diseases is increasing rapidly across regions due to aging population, unhealthy food habits, and rise in obesity. According to Partnership to Fight Chronic Disease (PFCD), chronic diseases are the leading cause of death and disability in the U.S. Nearly 133 million people in the U.S., or 45% of the population, have at least one chronic disease. These factors fuel the growth of the global mHealth monitoring diagnostic medical devices market.
  • High prevalence of diabetes and improvement in economic conditions are anticipated to propel demand for wearable devices. According to the International Diabetes Federation (IDF), more than 382 million people across the globe currently suffer from diabetes.
  • Increase in government initiatives for the adoption of mhealth products is likely to propel the global market during the forecast period. Governments are making efforts to increase awareness among health care professionals and patients about the usage and benefits of mHealth monitoring diagnostic medical devices.
  • Governments in developed countries such as the U.S. have begun to reach local communities by offering Continual Medical Education (CME) classes. This leads to increase in awareness among physicians and surgeons about the availability and usage of mHealth monitoring diagnostic medical devices. This is projected to augment the growth of the global mHealth monitoring diagnostic medical devices market.
  • In July 2017, the European Commission launched public discussion on how it should promote digital innovation in health care for the advantage of citizens and health systems in Europe 

Request PDF Sample of mHealth Monitoring Diagnostic Medical Devices Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2018

Focus on Geographic Expansion

  • Companies in the global mHealth monitoring diagnostic medical devices market are undergoing strategic acquisitions which enable product distribution in various regions and also strengthen their global presence. Rise in demand for technology-driven solutions, economic growth, and increase in awareness about chronic disorders present significant opportunities for players operating in the global mHealth monitoring diagnostic medical devices
  • In April 2017, NextGen Healthcare, a subsidiary of Quality Systems and a provider of computer-based practice management applications for medical and dental group practices, acquired Entrada, a provider of mobile clinical documentation for ~US$ 34 Mn all in cash. The seller was represented by JEGI. 

High Cost and Cyber Threat to Hamper Market

  • The global mHealth monitoring diagnostic medical devices market is technology driven. Introduction of new technologies in the market increases the demand for these systems due to improved efficiency and outcomes. However, high cost of these new devices raises the affordability issue, which hampers the growth of the global mHealth monitoring diagnostic medical devices market, especially in the developing countries. Moreover, lack of reimbursement affects demand for mHealth monitoring diagnostic medical devices.
  • mHealth monitoring diagnostic medical devices have been adopted by patients, therapists, and doctors in the last decade. However, data security breaches have been reported. Hence, cyber threat and increase in data security breaches hamper market growth.

Buy Now “mHealth Monitoring Diagnostic Medical Devices Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=2018&ltype=S

Global mHealth Monitoring Diagnostic Medical Devices Market: Competitive Landscape

  • This report profiles major players in the global mHealth monitoring diagnostic medical devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global mHealth monitoring diagnostic medical devices market is fragmented, with the presence of a number of international as well as regional players
  • Various in the global mHealth monitoring diagnostic medical devices market are
    • Dexcom, Inc.
    • Apple, Inc.
    • FitBit, Inc.
    • Withings (Nokia)
    • Proteus Digital Health
    • Omada Health, Inc
    • WellDoc, Inc.
    • Livongo Health
    • Noom, Inc.
    • Ginger.io, Inc.
    • Propeller Health
    • 2Morrow, Inc.
    • Canary Health
    • Mango Health
    • BiogeniQ Inc.
    • Twine Health, Inc.
    • Glooko, Inc.
    • Firstbeat Technologies Ltd
    • Claritas MindSciences
    • Big Health
    • Dthera Sciences
    • Virta Health Corp
    • Zest Health, LLC
    • Meru Health, Inc.
    • HealthMine, Inc.
    • Pear Therapeutics, Inc.
    • BioTelemetry, Inc
    • Blue Mesa Health
    • Digital Therapeutics
  • which account for more than 80% share of the market

Global mHealth Monitoring Diagnostic Medical Devices Market: Key Developments

Key players in the global mHealth monitoring diagnostic medical devices market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global mHealth monitoring diagnostic medical devices market. A few expansion strategies adopted by players operating in the global mHealth monitoring diagnostic medical devices market are:

  • In January 2018, Apple, Inc. announced an update to the Health app with the iOS 11.3 beta, debuting a feature for customers to see their medical records right on their iPhone. The updated Health Records section within the Health app brings together hospitals, clinics, and the existing Health app to make it easy for consumers to see their available medical data from multiple providers.
  • In September 2017, Cerebra Health acquired Younes Medical Technologies, a developer of sleep scoring technology
  • In June 2017, DexCom, Inc. received the Food and Drug Administration (FDA) approval for the Dexcom G5 mobile app for Android devices
  • In July 2017, Fitbit and DexCom, Inc. entered into collaboration to develop and market products to help people better manage their diabetes and get a more complete picture of their overall health with easy-to-use mobile tools
  • In July 2017, Royal Philips announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Philips BlueControl wearable light therapy device to treat mild psoriasis

More Trending Reports by Transparency Market Research –

Gout Therapeutic Market: globenewswire.com/news-release/2019/06/03/1863351/0/en/Gout-Therapeutic-Market-is-projected-to-reach-US-3820-Million-by-2027-TMR.html

Heparin Market: globenewswire.com/news-release/2017/11/08/1177610/0/en/Heparin-Market-to-Reach-a-Valuation-of-US-16-3-Billion-by-the-End-of-2025-Transparency-Market-Research.html

0 votes

Intravenous Catheters Market: Introduction

  • The catheters that are utilized to access the patient’s vascular system through veins are known as intravenous catheters. These catheters are thin tubes that are used to serve various medical purposes such as use in administration of medications, surgical procedures, removal of body fluids, and treating diseases. Intravenous catheters are available in two different forms: midline peripheral catheters and central catheters.

Report Overview @ https://www.transparencymarketresearch.com/intravenous-catheters-market.html

  • Intravenous catheters are inserted into a vein in a patient’s body and positioned within the same either to deliver various therapeutics into the patient’s bloodstream or to withdraw blood mainly for diagnostic testing. Rise in global incidence rates of chronic diseases such as diabetes, cancer, and acute infectious diseases, along with cardiovascular disorders, has tremendously increased the demand for intravenous catheters used to administer drugs to patients
  • Moreover, increase in elderly population across the globe is a contributor to this rising demand for intravenous catheters

Get a Glimpse of the In-Depth Analysis through our Comprehensive “Intravenous Catheters Market” Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75417

Key Drivers and Restraints of Global Intravenous Catheters Market

  • Rise in Incidence of Target Diseases such as Cancer and Viral Infections Drives Global Market
    • Intravenous catheters devices are used for the delivery of various medications such as analgesics, antipyretics, anesthesia, and anticancer drugs. Increase in incidence of viral infections, cancer, and tuberculosis (TB) is expected to boost the intravenous catheters market, The most common use of intravenous catheters is for the administration of antiviral drugs and analgesics.  
    • According to statistics published by UNAIDS, around 37.9 million individuals globally were living with HIV at the end of 2018 and around 1.7 million people became newly infected by HIV in 2018 due to the changing lifestyles. This number is expected to grow in the near future.
    • Similarly, increase in number of cancer patients is likely to augment the market, since these patients require administration of drugs and analgesic agents at regular intervals. It has been projected by the WHO that by 2030, around 13.1 million people would die from cancer worldwide.
    • This alarming increase in number of cancer patients is expected to increase the utilization of intravenous catheters
    • Thus, rise in incidence of target diseases such as cancer and viral infections is expected to propel the global intravenous catheters market during the forecast period

Intravenous Catheters Market: Segmentation

  • Based on product type, the global intravenous catheters market can be segmented into midline peripheral catheters and central catheters
  • Midline peripheral catheters are the venous access devices that range between 3 to 10 inches in length. These catheters are usually placed in the vein of the upper arm – the cephalic vein that is below the level of axillary line.
  • Central catheters are inserted in veins within the patient’s thorax. The physicians prefer to use a central catheter when administration of intravenous (IV) fluids, blood products, and medication is required in large volumes and for longer durations in the patients.
  • Central catheters are further segmented into peripherally inserted central catheters (PICC) and central venous catheters
  • Based on end-user, the global intravenous catheters market can be categorized into hospitals, long term care centers, ambulatory surgical centers, dialysis centers, and others

Pre Book “Intravenous Catheters Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=75417&ltype=S

Emerging Economies to Offer Growth Opportunities

  • In terms of region, the global intravenous catheters market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is expected to constitute the largest market for intravenous catheters. Rise in prevalence of cancer in the U.S. and Canada has increased the demand for its early diagnosis and treatment. Intravenous catheters play a key role in the diagnosis and treatment of almost every disease. According to the American Cancer Society (ACS), in 2018, around 1,735,350 new cases of cancer were reported in the U.S. and over 609,640 patients died due to cancer in the same year. This increase in cancer patient population and deaths occurring due to the disease is one of the primary reasons for the growth of intravenous catheters market in North America.

Key Manufactures Operating in Global Market

The global intravenous catheters market was highly fragmented in 2018. Key players operating in the global intravenous catheters market include:

  • Becton Dickinson and Company
  • Braun Melsungen AG
  • Smith Medical
  • Terumo Corporation
  • Vygon Group
...